Recurrent Pregnancy Loss (RPL) in Pune: Causes, Diagnosis & Path to a Successful Pregnancy

Recurrent pregnancy loss is defined by most international reproductive medicine bodies — including the American Society for Reproductive Medicine (ASRM) and the Royal College of Obstetricians and Gynaecologists (RCOG) — as two or more clinical pregnancy losses. Some Indian clinicians and guidelines still use three losses as the threshold, which is why couples in Pune are sometimes told to 'wait and try again' after a second loss. HomeIVF Medical Board recommends starting a formal RPL investigation after two losses, particularly if the woman is over 35 or has other risk factors.

It is important to distinguish RPL from infertility. Couples with RPL can conceive — sometimes easily — but pregnancies do not progress to viability. This distinction matters enormously for the diagnostic and therapeutic approach. A biochemical pregnancy (a very early loss detected only by blood hCG) may or may not be counted depending on the clinical context, and your HomeIVF specialist will help you interpret your specific history accurately before ordering tests.

Chromosomal or genetic abnormalities in the embryo remain the single most common cause of RPL, responsible for the majority of first-trimester losses. These are largely random events linked to egg or sperm quality, and they become more frequent as maternal age increases — a pattern increasingly seen in Pune's urban, career-focused demographic, where many women attempt their first pregnancy in their mid-to-late thirties.

Beyond chromosomal causes, the following are well-established contributors: uterine structural abnormalities (septate uterus, fibroids inside the cavity, polyps, or intrauterine adhesions); antiphospholipid syndrome (APS), an autoimmune clotting disorder found in roughly 15% of RPL patients; thrombophilia disorders including Factor V Leiden mutations; hormonal imbalances such as poorly controlled hypothyroidism, PCOS, or elevated prolactin; and male-factor contributions including high sperm DNA fragmentation, which is under-investigated in many Indian clinics.

Lifestyle factors prevalent in Pune's IT and corporate workforce — chronic stress, irregular sleep cycles, sedentary work, and environmental pollutants near industrial corridors — may also influence embryo quality and uterine receptivity, though their independent causal weight is still being quantified in research.

RPL does not always announce itself with dramatic symptoms. Many losses occur before 10 weeks and may feel similar to a heavy, painful period. However, certain warning signs should prompt immediate medical attention and — if you have had a prior loss — a proactive consultation rather than a wait-and-see approach.

Warning signs during pregnancy include: vaginal bleeding or spotting in the first trimester, severe one-sided pelvic pain (which may indicate ectopic pregnancy, a related but distinct emergency), and an absence of typical pregnancy symptoms (nausea, breast tenderness) that had previously been present. On ultrasound, a missed miscarriage — where fetal cardiac activity stops without external symptoms — is increasingly detected early due to routine first-trimester scans, which are now widely available across localities like Baner and Hadapsar.

Between pregnancies, symptoms that may point to an underlying RPL cause include irregular menstrual cycles, very heavy or very light periods (which can indicate uterine cavity issues), recurrent urinary tract infections (linked to uterine anomalies), and joint pain or skin rashes alongside pregnancy losses (which may suggest autoimmune involvement). Do not wait for a third loss to seek answers.

The clearest clinical answer: after your second pregnancy loss, book a specialist consultation — not a general OB-GYN visit, but a reproductive medicine expert with access to a full RPL investigation panel. This is particularly urgent if you are over 35, have a known thyroid disorder, have previously been diagnosed with PCOS, or if your partner has never had a semen analysis with DNA fragmentation testing.

For couples in areas like Viman Nagar or Kothrud where traffic and working hours can make clinic visits logistically difficult, HomeIVF offers a fully virtual first consultation where a senior fertility specialist reviews your complete history, orders the appropriate tests through home sample collection, and creates a personalised RPL investigation plan — all without a single hospital visit for the initial work-up.

Do not self-diagnose or rely on online forums. RPL has multiple causes that require sequential, evidence-based testing. Self-medicating with progesterone or aspirin — both commonly self-prescribed among Pune patients based on WhatsApp advice — without a confirmed diagnosis can delay appropriate treatment and, in rare cases, cause harm. Early, expert-guided evaluation is always the faster path to a healthy pregnancy.

A thorough RPL panel typically covers four domains: genetic, anatomical, immunological/haematological, and endocrine. Here is what Pune couples can expect when HomeIVF Medical Board initiates a systematic investigation.

Genetic testing includes parental karyotyping (a blood test for both partners) to detect balanced chromosomal translocations, which are present in about 3-5% of RPL couples but dramatically increase miscarriage risk. If pregnancy tissue is available from a recent loss, products of conception (POC) analysis can reveal whether the embryo had an aneuploidy.

Anatomical assessment is best performed with a saline infusion sonography (SIS) or a hysteroscopy, which can detect intrauterine septa, polyps, or adhesions with far greater accuracy than a standard transvaginal ultrasound. Endocrine tests cover TSH, free T4, prolactin, fasting insulin, AMH, and Day 2-3 FSH/LH/oestradiol. Immunological tests include antiphospholipid antibodies (anticardiolipin and lupus anticoagulant), tested twice at least 12 weeks apart for a valid APS diagnosis. Thrombophilia panels (MTHFR, Factor V Leiden, Protein C and S) are ordered based on clinical risk assessment. Sperm DNA fragmentation (SDF) testing for the male partner is a critical addition that HomeIVF Medical Board specifically recommends, as high SDF is an under-recognised contributor to RPL.

Treatment for RPL is cause-specific, which is precisely why diagnosis must come first. HomeIVF Medical Board creates individualised protocols based on each couple's investigation results rather than applying a one-size-fits-all approach.

For couples with confirmed antiphospholipid syndrome, a combination of low-dose aspirin and low-molecular-weight heparin during pregnancy has strong evidence supporting improved live birth rates. Thyroid or prolactin abnormalities are corrected with targeted medication prior to the next conception attempt. Uterine structural issues — septa, polyps, or adhesions — are addressed through hysteroscopic surgery, after which conception can typically be attempted within one to three cycles.

For couples with no identified cause (unexplained RPL), or where high embryo aneuploidy rates are suspected, preimplantation genetic testing for aneuploidies (PGT-A) combined with IVF is the most evidence-backed pathway to selecting chromosomally normal embryos for transfer. HomeIVF coordinates this process end-to-end, including ovarian stimulation monitoring at home, embryo biopsy at a partner laboratory, and frozen embryo transfer with luteal phase support. IVF packages on HomeIVF start from ₹1.5 lakh, making this pathway accessible to Pune families across income levels. Lifestyle modifications — including weight optimisation, stress management, and correction of vitamin D or folate deficiency — are integrated into every protocol.

One of the most consistent barriers RPL patients in Pune describe is the sheer logistical burden of care. Multiple blood draws, repeated follicular monitoring scans, and frequent in-clinic consultations during a treatment cycle are physically and emotionally exhausting — particularly for working professionals in IT parks near Baner or Hinjewadi, or for couples managing joint families in older residential neighbourhoods like Kothrud or Sadashiv Peth.

HomeIVF's platform delivers senior-specialist fertility care directly to your home. Certified phlebotomists collect blood samples at your doorstep, trained sonographers conduct follicular monitoring scans in your residence, and your assigned HomeIVF coordinator tracks every result on an AI-powered dashboard that flags abnormal values within hours. Video consultations with reproductive specialists can be scheduled around your work calendar, and your digital prescription and cycle records are accessible at any time via the HomeIVF app.

This model does not compromise clinical quality — HomeIVF's partner laboratories are NABL-accredited, ultrasound equipment meets hospital-grade specifications, and every care protocol is reviewed by the HomeIVF Medical Board. The result is that couples in Pune receive the same rigorous RPL care that was previously available only to those who could afford long clinic queues or out-of-city medical travel.

Prognosis after RPL treatment depends heavily on the underlying cause, the woman's age, and ovarian reserve. Couples with an identified and treatable cause — such as APS, corrected thyroid disease, or a resected uterine septum — typically see live birth rates of 70-80% in subsequent pregnancies with appropriate management. Couples with unexplained RPL who undergo PGT-A-screened frozen embryo transfer report live birth rates of 60-75% per transfer cycle in most published series, though individual outcomes vary.

Age is a consistent modifier: a 32-year-old woman in Pune with two losses and a normal RPL panel has an excellent prognosis with supportive care alone. A 40-year-old with three losses and diminished ovarian reserve may need PGT-A and potentially donor egg IVF to achieve the best outcomes. HomeIVF Medical Board believes in honest, age-specific counselling — couples deserve realistic optimism, not false guarantees.

Emotional support is inseparable from clinical success. RPL takes a severe psychological toll, with clinical anxiety and depression documented in up to 40% of affected women. HomeIVF integrates access to fertility-specialist counsellors into every RPL care pathway, recognising that mental well-being is a medical variable — not a luxury add-on.